Followers | 145 |
Posts | 27561 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Friday, April 17, 2020 6:42:49 AM
from my bank account. I left some
shares just for academic interest.
KTOV was one on my largest failures,
although i am in the deep red i still
keep it, for offsetting some gains in
others some time.
PARS was my largest loss by far, a
few years ago
TEVA was my largest gain ever.
BVXV has imo the largest potential if
of course they achieve FDA approval.
That said, there have been great Israeli
bio company success stories, and some
loud shattering collapses as well.
Take into consideration that Israel is #1
in foreign companies listed in the US.
Good Luck
Recent SLGL News
- Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2024 01:29:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/29/2024 01:07:53 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/23/2024 11:49:02 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/17/2024 09:05:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/30/2023 12:10:12 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2023 01:20:38 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/09/2023 08:41:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/09/2023 12:15:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/28/2023 12:31:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/27/2023 12:03:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/26/2023 12:48:01 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/10/2023 11:20:35 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/10/2023 11:10:27 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/27/2023 08:05:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/24/2023 10:20:14 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 07/20/2023 10:00:47 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM